DexCom (DXCM) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $69.07 --0%
Revenue Growth %: +11.2%
Financial Fact:
Interest expense: -200K
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +11.2%
Financial Fact:
Interest expense: -200K
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q4 EPS of $0.02, $0.01 better than the analyst estimate of $0.01. Revenue for the quarter came in at $130.8 million versus the consensus estimate of $123.74 million.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Starts DexCom (DXCM) at Buy
- Bernstein SocGen Reiterates Outperform Rating on Fervo Energy (FRVO)
- Dexcom Further Advances Vision of Glucose Biosensing for All
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
